[go: up one dir, main page]

AU2882577A - Pharmaceutical dosage forms - Google Patents

Pharmaceutical dosage forms

Info

Publication number
AU2882577A
AU2882577A AU28825/77A AU2882577A AU2882577A AU 2882577 A AU2882577 A AU 2882577A AU 28825/77 A AU28825/77 A AU 28825/77A AU 2882577 A AU2882577 A AU 2882577A AU 2882577 A AU2882577 A AU 2882577A
Authority
AU
Australia
Prior art keywords
dosage forms
pharmaceutical dosage
pharmaceutical
forms
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU28825/77A
Other versions
AU513845B2 (en
Inventor
G. KE. Peach J. M. Du Mayne J. D. and Ho D. S. S Gregory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB41483/76A external-priority patent/GB1548022A/en
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Publication of AU2882577A publication Critical patent/AU2882577A/en
Application granted granted Critical
Publication of AU513845B2 publication Critical patent/AU513845B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU28825/77A 1976-10-06 1977-09-15 Pharmaceutical dosage forms Expired AU513845B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1,483/76 1976-10-06
GB41483/76A GB1548022A (en) 1976-10-06 1976-10-06 Pharmaceutial dosage forms
GBGB30,399/7 1977-07-20
GB3039977 1977-07-20

Publications (2)

Publication Number Publication Date
AU2882577A true AU2882577A (en) 1979-03-22
AU513845B2 AU513845B2 (en) 1981-01-08

Family

ID=26260429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28825/77A Expired AU513845B2 (en) 1976-10-06 1977-09-15 Pharmaceutical dosage forms

Country Status (12)

Country Link
JP (1) JPS5344619A (en)
AU (1) AU513845B2 (en)
CH (1) CH633717A5 (en)
CY (1) CY1129A (en)
DE (1) DE2744493A1 (en)
FR (1) FR2366835A1 (en)
HK (1) HK58081A (en)
IE (1) IE45770B1 (en)
KE (1) KE3171A (en)
LU (1) LU78259A1 (en)
MY (1) MY8200187A (en)
NL (1) NL189898C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623779B2 (en) * 1989-05-24 1992-05-21 Rhone-Poulenc Sante New porus pharmaceutical form and its preparation

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455459A1 (en) * 1979-05-02 1980-11-28 Sertog Carboxy:methylcellulose matrix for slow release of volatile cpd. - contains tri:ethanolamine, stearin and an alcohol e.g. cetyl is esp. useful for perfumes, insect repellents eczema treatment etc.
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
AT385200B (en) * 1986-07-22 1988-02-25 Kwizda Fa F Johann Process for the production of tablets with delayed release characteristics of medicinal substances
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4767789A (en) * 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
US4771077A (en) * 1986-10-21 1988-09-13 American Home Products Corporation (Del.) Spray dried acetaminophen
FR2634376B1 (en) 1988-07-21 1992-04-17 Farmalyoc NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
JPH02247447A (en) * 1989-03-17 1990-10-03 Matsushita Refrig Co Ltd Control method for air conditioner
JPH0331644A (en) * 1989-06-28 1991-02-12 Matsushita Refrig Co Ltd Air conditioner control device
FR2657258A1 (en) 1990-01-19 1991-07-26 Farmalyoc NOVEL UNITARY, SOLID, POROUS FORM COMPRISING PARTICLES IN THE FORM OF PEARLS AND ITS PREPARATION.
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
DK0617613T3 (en) * 1991-12-20 1996-06-17 Pfizer Porous shaped delivery devices and method of making them
KR100256147B1 (en) 1991-12-24 2000-08-01 오노다 마사요시 Oral disintegrating preparations and preparation method thereof
DE4221880A1 (en) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Solid and liquid solutions of poorly water-soluble drugs
DE4342091A1 (en) * 1993-12-09 1995-06-14 Asta Medica Ag Products for the application of initially high doses of Cetrorelix and manufacture of a combination pack for use in the treatment of diseases
US5763476A (en) * 1994-03-02 1998-06-09 Akzo Noble N.V. Sublingual or buccal pharmaceutical composition
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EA001898B1 (en) 1996-06-14 2001-10-22 Киова Хакко Когио Ко., Лтд. Intraorally rapidly disintegrating tablet
GB9717770D0 (en) * 1997-08-21 1997-10-29 Scherer Ltd R P Pharmaceutical composition
HUP0003917A3 (en) * 1997-10-08 2001-04-28 Sepracor Inc Marlborough Dosage form for aerosol administration of water-sensitive medicaments
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
GB9722682D0 (en) * 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP4173670B2 (en) * 2002-03-08 2008-10-29 旭化成ファーマ株式会社 Orally disintegrating preparation
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
MXPA05009079A (en) * 2003-02-28 2006-05-19 Alk Abello As Dosage form having a saccharide matrix.
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
ES2409347T3 (en) 2004-10-21 2013-06-26 Aptalis Pharmatech, Inc. Pharmaceutical compositions of masked flavor with gastro-soluble porogenic agents
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20080031944A1 (en) * 2006-08-04 2008-02-07 Cima Labs Inc. Stabilization of lorazepam
CN102958515A (en) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 Fexofenadine microcapsules and compositions containing them
JP2012121850A (en) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd Oral fast-dissolving composition of aripiprazole
JP2015172084A (en) * 2015-07-06 2015-10-01 大塚製薬株式会社 Quickly-soluble oral composition of aripiprazole
JP6572257B2 (en) * 2017-05-16 2019-09-04 大塚製薬株式会社 Aripiprazole oral fast-dissolving composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) * 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB836811A (en) * 1955-07-08 1960-06-09 Ciba Ltd Shaped medicament carriers and process for their manufacture
GB1083896A (en) * 1964-04-30 1967-09-20 Dunster Lab Ltd Vehicles for administering drugs
DE2017373A1 (en) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophilized products and processes for their manufacture
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
DE2246013A1 (en) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh PROCESS FOR THE MANUFACTURING OF POROUS TABLETS
DE2556561C2 (en) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Process for the production of porous tablets

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623779B2 (en) * 1989-05-24 1992-05-21 Rhone-Poulenc Sante New porus pharmaceutical form and its preparation

Also Published As

Publication number Publication date
HK58081A (en) 1981-12-04
IE45770B1 (en) 1982-11-17
IE45770L (en) 1978-04-06
JPS5344619A (en) 1978-04-21
AU513845B2 (en) 1981-01-08
MY8200187A (en) 1982-12-31
KE3171A (en) 1981-12-18
DE2744493C2 (en) 1991-07-18
DE2744493A1 (en) 1978-04-13
LU78259A1 (en) 1978-06-09
CH633717A5 (en) 1982-12-31
FR2366835A1 (en) 1978-05-05
FR2366835B1 (en) 1980-10-24
NL189898C (en) 1993-09-01
JPS6250445B2 (en) 1987-10-24
NL189898B (en) 1993-04-01
NL7710876A (en) 1978-04-10
CY1129A (en) 1982-02-19

Similar Documents

Publication Publication Date Title
AU513845B2 (en) Pharmaceutical dosage forms
AU515341B2 (en) Pharmaceutical composition
AU514195B2 (en) Dosage form
JPS52143218A (en) Pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
JPS5362838A (en) Pharmaceutical composition
AU521053B2 (en) Medicament dosage form
JPS5372814A (en) Pharmaceutical composition
AU3191277A (en) Tumour-resolving medicament
AU507700B2 (en) Pharmaceutical filter
AU504182B2 (en) Pharmaceutical dosage forms
AU513829B2 (en) Modified montmorillonite pharmaceutical
AU3152677A (en) Pharmaceutical composition
JPS52128357A (en) Antiitumor drug
AU2649977A (en) Pharmaceutical composition
JPS5356634A (en) Pharmaceutical composition
AU508191B2 (en) Pharmaceutical composition
JPS5325579A (en) Pharmaceutical compound
JPS5283918A (en) Pharmaceutical composition
AU517608B2 (en) Medicaments
ZA777335B (en) Pharmaceutical compounds
JPS52143220A (en) Tablet type pharmaceutical composition
JPS5338620A (en) Isomalin antiimold drug
ZA776645B (en) Pharmaceutical preparations
JPS52122633A (en) Pharmaceutical composition